274 results on '"Venneti, Sriram"'
Search Results
2. Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline glioma
3. Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations
4. Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways
5. An ERK5-PFKFB3 axis regulates glycolysis and represents a therapeutic vulnerability in pediatric diffuse midline glioma
6. Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial
7. Recurrent ACVR1 mutations in posterior fossa ependymoma
8. Autopsy findings of previously described case of diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma
9. Everolimus improves the efficacy of dasatinib in PDGFR[alpha]-driven glioma
10. H3K27M-mutant diffuse midline glioma with extensive intratumoral microthrombi in a young adult with COVID-19-associated coagulopathy
11. Incidental Massive Hydrocephalus Associated With an Unruptured Choroid Plexus Arteriovenous Malformation and Complete Agenesis of the Corpus Callosum Found in an Adult at Autopsy
12. CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
13. SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer
14. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape
15. Metabolomic Profiles of Human Glioma Inform Patient Survival.
16. Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas
17. Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome
18. Non-invasive metabolic imaging of brain tumours in the era of precision medicine
19. Akt-Dependent Metabolic Reprogramming Regulates Tumor Cell Histone Acetylation
20. Blood-brain barrier–adapted precision medicine therapy for pediatric brain tumors
21. miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma
22. CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response
23. Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG Registry
24. BRAF activating mutations involving the β3-αC loop in V600E-negative anaplastic pleomorphic xanthoastrocytoma
25. 20 - Immunohistology of the Nervous System
26. Multi-focal sequencing of a diffuse intrinsic pontine glioma establishes PTEN loss as an early event
27. A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas
28. A road map for the treatment of pediatric diffuse midline glioma
29. Prion Diseases
30. Metabolic Reprogramming in Brain Cancer: A Coordinated Effort
31. 2-Hydoxyglutarate: D/Riving Pathology in gLiomaS
32. PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
33. Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases
34. Imaging Microglial Activation During Neuroinflammation and Alzheimer’s Disease
35. Everolimus improves the efficacy of dasatinib in the treatment of PDGFRA-driven glioma
36. The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: Implications for PET imaging
37. PDGFRA Amplification is Common in Pediatric and Adult High-Grade Astrocytomas and Identifies a Poor Prognostic Group in IDH1 Mutant Glioblastoma
38. Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant Glioblastomas
39. Histone 3 Lysine 9 Trimethylation Is Differentially Associated With Isocitrate Dehydrogenase Mutations in Oligodendrogliomas and High-Grade Astrocytomas
40. Metabolic Modulation of Epigenetics in Gliomas
41. Endoscopic Endonasal Resection of Anterior Skull Base Meningiomas and Mucosa: Implications for Resection, Reconstruction, and Recurrence
42. Molecular Imaging of Microglia/Macrophages in the Brain
43. MiRNA-9 and MiRNA-200a Distinguish Hemangioblastomas from Metastatic Clear Cell Renal Cell Carcinomas in the CNS
44. Ganglioglioma arising from dysplastic cortex
45. Isocitrate Dehydrogenase 1 Analysis Differentiates Gangliogliomas from Infiltrative Gliomas
46. p16INK4A and p14ARF Tumor Suppressor Pathways Are Deregulated in Malignant Rhabdoid Tumors
47. Chapter 20 - Immunohistology of the Nervous System
48. Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer Disease
49. The Positron Emission Tomography Ligand DAA1106 Binds With High Affinity to Activated Microglia in Human Neurological Disorders
50. A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.